FOLD vs KEY · rev $528.3M vs P/E 13, rev $7.51B
Amicus Therapeutics Inc (FOLD) versus KeyCorp (KEY) — a side-by-side from cached financials, not a winner call.
Amicus Therapeutics Inc (FOLD) is a biotechnology company listed on US.
KeyCorp (KEY) is a banks - regional company listed on US.
Latest reported FOLD revenue for 2024-12-31 was $528.3M. Net income was -$56.1M. Revenue was up 32.3% from 2023-12-31 to 2024-12-31. FOLD currently screens at market cap $1.80B.
Latest reported KEY revenue for 2025-12-31 was $7.51B. Net income was $1.83B. Revenue was up 62.7% from 2024-12-31 to 2025-12-31. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
FOLD currently screens at market cap $1.80B. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
Not investment advice. Open the FOLD and KEY stock pages for the full models.
Not investment advice.